INTRODUCTION
Rheumatoid arthritis (RA) is a chronic autoimmune disease resulting in joint inflammation and destruction. A strong association between RA and an increased risk of cardiovascular disease (CVD), due to accelerated atherosclerosis, has been established (1, 2) . In this regard, different studies show that dyslipidemia is highly prevalent in patients with RA and may be present at least 10 years before the onset of the disease (3) (4) (5) . However, a relationship between an altered lipid profile in plasma and the augmented incidence of CVD in RA patients has not been clearly proven and is still the subject of intense debate (6, 7) .
On the other hand, dyslipidemia can trigger or potentiate already existing inflammatory responses and thereby enhance the severity of RA. Oxidized low-density lipoproteins (oxLDL) that accumulate in the macrophages of the arterial intima during hypercholesterolemia are good activators of toll-like receptor 4 (TLR4), acting as endogenous danger-associated molecular patterns (DAMP) (8) . Also, it has been reported that in T cells from systemic lupus erythematosus patients, dyslipidemia may potentiate antigen receptor signalling through the increase of glycosphingolipid synthesis and their incorporation into membrane lipid rafts (9) . Accordingly, a relationship between hypercholesterolemia and RA severity has been established (10) although it has not been confirmed by others (11) .
Experimental animal models of RA in association with dyslipidemia constitute excellent tools to explore some of above mentioned questions. In this regard, we and others have recently shown that ApoE (ApoE of innate immune responses (13) . Accordingly, these experimental models can be used to explore whether the accelerated arthritis observed in ApoE -/-is related to the hypercholesterolemia characteristic of these mutant mice and/or to the lack of some of the previously identified anti-inflammatory properties of ApoE, that are unrelated to its function in the control of cholesterol metabolism (14) . In the present study, we have explored these questions comparing the severity of CIA between mice expressing different amounts of ApoE in the context of either normal or altered circulating cholesterol levels.
MATERIALS AND METHODS
Mice. 
Serological studies.
Total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-c),
LDL/VLDL-c and triglyceride levels in serum samples were determined using an autoanalyzer (Biosystems SA, Barcelona, Spain) following manufacturer instructions.
Serum levels of IgG1 and IgG2a anti-col II antibodies were measured by ELISA as described (12) . Results were expressed in titration units/ml (U/ml) in reference to a standard curve obtained from a serum pool of col II-CFA immunized DBA/1 mice.
Circulating levels of ApoE were determined by ELISA as described (16 was oxidized alone with 2.5 µM CuSO 4 or in the presence of equal concentrations of HDL phospholipids from each experimental group (0.1mM phospholipids). The oxidation kinetics were followed through continuous monitoring of the formation of conjugated diene at 37ºC for 4h (17) . The kinetics of LDL in the LDL + HDL incubations were calculated by subtracting the kinetics of HDL incubated without LDL.
The lag phases were calculated and the results represented as relative lag phase to the LDL kinetics oxidized without HDL. (17) . Paraoxonase (PON)-1 was measured using phenylacetate as substrate (17).
Cytokine expression.
The expression of mRNAs encoding for interleukin-1β (IL-1β), tumor necrosis factor-α (TNFα), IL-6, transforming growth factor-β (TGFβ) and IL-10 cytokines was explored in the paws before col II immunization and 8 weeks after using quantitative 
Statistical analysis.
The differences between the two groups were analyzed by a 2-tailed Student's t or 2-sample Mann-Whitney U tests. Probability values <0.05 were considered significant.
RESULTS
The severity of CIA in ApoE mutant mice directly correlates with the levels of circulating ApoE.
We and others have recently reported the development of an exacerbated inflammatory arthritis in mice deficient in ApoE (12, 13) . To analyze whether the enhanced disease in these mutant mice was related to the hypercholesterolemia and/or to the absence of ApoE, we compared the development of CIA between B10.RIII.WT, Figure 1A and B), in comparison to both B10.RIII.WT and B10.RIII.ApoE +/-mice.
As previously described (12) , the severity of CIA in B10.RIII.ApoE -/-mice was higher than in B10.RIII.WT mice (Figure 2 ). In inverse correlation with serum levels of ApoE, the clinical severity of CIA in B10.RIII.ApoE +/-mice was also significantly higher than in B10.RIII.WT controls but lower than in B10.RIII.ApoE -/-mice ( Figure   2A ). This was confirmed by analyzing different radiological signs associated with bone and cartilage damage. 
Functional properties of HDL in ApoE mutant mice.
ApoE is a component of HDL particles (20) . In addition, chronic inflammation has been shown to alter the anti-inflammatory properties of HDLs transforming them into pro-inflammatory molecules (20, 21 mice exhibited increased levels of TC and LDL/VLDL-c in sera when fed with a NCD and these levels were even higher under a HCD ( Figure 5A : p<0.001 in all cases). These abnormal circulating lipid profiles of B10.RIII.LDLR -/-mice were similar before and after CIA induction ( Figure 5A ). In association with the presence of hypercholesterolemia, very high levels of circulating ApoE were found in B10.RIII.LDLR -/-mice fed with NCD and these levels increased with the HCD, both before and after CIA induction ( Figure 5B) . A significant reduction in circulating TC and HDL-c, but not LDL/VLDL-c, concentrations was again observed in B10.RIII.WT mice fed with a NCD, but not with a HCD, during the development of CIA, ( Figure   5A ). In these WT mice, the type of diet had no effect on serum levels of ApoE neither before nor after col II immunization ( Figure 5B ).
Regardless of the diet received, no significant differences in the severity of clinical and radiological signs were observed between B10.RIII.LDLR -/-and B10.RIII.WT mice after CIA induction that were lower than in B10.RIII.ApoE -/-mice ( Figure 6 A-C). Similarly, paw expression of IL-1β, TNFα and IL-6 mRNAs was Figure 6D) . Again, the expression of TGFβ and IL-10 was similar in the different groups of mice after CIA induction (data not shown).
DISCUSSION
The deficiency of ApoE has recently been shown to exacerbate disease severity in two experimental models of autoimmune arthritis in mice by inducing inflammatory immune responses (12, 13 While an association between RA and increased risk of atherosclerosis and CVD has been strongly established (1, 2) , there exist controversies regarding the importance of dyslipidemia in this association (3) (4) (5) (6) (7) . Furthermore, some studies indicate that abnormal lipid profiles in sera, defined as high levels of TC and triglycerides and lower HDL-c levels, were present in more than 50% of patients with RA before or after disease diagnosis (3) (4) (5) . In contrast, studies show that a significant fraction of RA Previous observations demonstrate that small amounts of ApoE are sufficient to normalize plasma cholesterol levels and to inhibit atherosclerosis in mice (24, 25) . In our present study, we show an aggravation of CIA in B10.RIII.ApoE +/-mice having 30-50% of the circulating ApoE observed in WT mice but normal cholesterol profiles.
Independently of these dose-dependent differences, that may be related to the degree of systemic inflammation in each experimental model, both studies highlight the antiinflammatory role of ApoE in vivo that is unrelated of its activity in the control of cholesterol metabolism. The anti-inflammatory activity of ApoE has been demonstrated in several studies. ApoE-containing lipoproteins are very efficient suppressing mitogeninduced proliferative responses of T lymphocytes by reducing the production of IL-2 (18) . ApoE also regulates the TLR4-and TLR3-mediated production of IL-12 (26) and prevents the LPS-induced production of cytokines and subsequent death in rodents (27) .
Furthermore, an ectopic ApoE expression in macrophages and monocytes from ApoE -/-mice suppresses nuclear factor-κB-mediated inflammation by enhancing miR-146a levels (28) . In this regard, our results indicate that the partial or total ApoE deficiency modifies the polarization of macrophages after a potent inflammatory insult in vivo but has no effect on the in vitro activation of CD4 + cells. The anti-inflammatory capacity of ApoE appears to be isoform-dependent, and animals expressing the E4 allele have greater inflammatory responses (29) . Interestingly, there is one study that shows an association between the ApoE4 genotype and bone loss in human RA ( compatible with a role for hypercholesterolemia as an additional worsening factor for CIA severity in B10.RIII.ApoE -/-mice. In this regard, oxLDL and cholesterol crystals can act as DAMPs in the macrophages that infiltrate the arterial intima during hypercholesterolemia, activating TLR4 and NLRP3 inflammasome signalling pathways, respectively (8, 35) . Also, hypercholesterolemia can increase the content of lipid rafts in the plasma membrane, potentiating antigen receptor signalling in T cells (9) .
ApoE binds to members of the LDLR family, including the LDLR, LDLRrelated protein 1, VLDL receptor (VLDLR) and APOE receptor 2 (36) and several of these receptors have been involved in the anti-inflammatory effect of ApoE (19, 37) . This article is protected by copyright. All rights reserved.
